Tarik Asselah

29PUBLICATIONS
43CO-AUTHORS
Gene and molecular therapyMedical molecular engineering of nucleic acids and proteinsMedical virologyPredictive and prognostic markersCardiology (incl. cardiovascular diseases)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (29)

|May 28, 2026
Phase 3 Results of Bepirovirsen Treatment for Chronic Hepatitis B Virus Infection.

|Nov 10, 2025
A Phase 2 Trial of Tobevibart plus Elebsiran in Hepatitis D.

Tarik Asselah, Michael A Chattergoon, Alina Jucov

|Nov 05, 2025
Peginterferon alpha-2a add-on to siRNA JNJ-73763989 in untreated patients with HBeAg-positive chronic hepatitis B virus (HBV) infection: the phase 2 REEF-IT study.

Patrick T F Kennedy, Scott Fung, Maria Buti

|Mar 29, 2025
Reassessing the Safety of Bulevirtide in Chronic Hepatitis Delta: A Critical Perspective.

Tarik Asselah, Renee-Claude Mercier, Dmitry Manuilov

|Mar 15, 2025
Behaviour-Based Predictive Scores of Hepatocellular Carcinoma in People With Chronic Hepatitis B (ANRS CO22 HEPATHER).

Clémence Ramier, Camelia Protopopescu, Vincent Di Beo

|Mar 07, 2025
Systematic Screening for Hepatitis B, C, and HIV and Linkage to Care in Patients With Mental Health Disorders Admitted to the Emergency Department.

Prabakar Vaittinada Ayar, Jamal Abdelkader, Matthieu Gay

Pageof 5

Frequent Collaborators

3 joint publications

Patrick Marcellin

2 joint publications

Abdellah Mansouri

2 joint publications

Michael Biermer

2 joint publications

Sylvain Bodard